2026-01-04 - Analysis Report
Okay, here's a comprehensive analysis of Lam Research (LRCX) based on the provided data.

**1. Return Rate Comparison**

*   **Ticker:** LRCX
*   **Company Overview:** Lam Research Corp. designs, manufactures, markets, and services semiconductor processing equipment used in the fabrication of integrated circuits.
*   **LRCX Cumulative Return:** 244.51%
*   **S&P 500 (VOO) Cumulative Return:** 91.00%
*   **Divergence:**
    *   Current: 129.2
    *   Relative Divergence: 93.2

**Analysis:** LRCX has significantly outperformed the S&P 500, with a substantial divergence in cumulative returns.  The current divergence of 129.2 is quite high and the relative divergence of 93.2 indicates that the outperformance is near its peak level relative to its recent range. This suggests that LRCX is currently trading at a premium compared to the S&P 500, or that the market has a strong bullish bias towards the stock.

**Alpha, Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 1.0% | 34.2% | -2.0% | 1.6 | 17.2 |
| 2017-2019  | 38.0% | 34.2% | 21.0% | 1.7 | 36.9 |
| 2018-2020  | 57.0% | 34.2% | 36.0% | 1.5 | 59.5 |
| 2019-2021  | 105.0% | 24.5% | 62.0% | 1.6 | 90.7 |
| 2020-2022  | -11.0% | 49.0% | -9.0% | 1.6 | 53.0 |
| 2021-2023  | -14.0% | 49.0% | -15.0% | 1.8 | 98.8 |
| 2022-2024  | -47.0% | 42.4% | -66.0% | 1.9 | 91.1 |
| 2023-2025  | 150.0% | 43.7% | 88.0% | 2.0 | 215.9 |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate (CAGR) shows significant volatility, with very high growth in some periods (2019-2021, 2023-2025) and negative growth in others (2020-2022, 2021-2023, 2022-2024). The most recent period (2023-2025) shows extremely high growth.
*   **MDD:** Maximum Drawdown (MDD) indicates the largest peak-to-trough decline during the period, indicating risk. MDDs have varied, suggesting cyclical volatility.
*   **Alpha:** Alpha measures performance relative to a benchmark (in this case, likely the S&P 500). Positive alpha indicates outperformance, and negative alpha indicates underperformance.  The alpha values are highly variable, mirroring the CAGR fluctuations.
*   **Beta:** Beta measures the stock's volatility relative to the market. A Beta above 1 indicates the stock is more volatile than the market. LRCX consistently has a beta above 1, suggesting higher volatility. The Beta has been trending upwards, reaching 2.0 in the most recent period.
*   **Cap(B):** Market Capitalization in Billions (B). The market cap has generally increased over time, with a significant jump in the most recent period.

**2. Recent Stock Price Fluctuations**

*   **Close:** 185.06
*   **Last-market:** price: 185.06, previousClose: 171.18, change: 8.11
*   **5-day SMA:** 176.79
*   **20-day SMA:** 168.65
*   **60-day SMA:** 156.90

**Analysis:** The stock price is above all three Simple Moving Averages (SMAs), which is a bullish signal. The 5-day SMA is above the 20-day SMA, and the 20-day SMA is above the 60-day SMA. This is another indication of an upward trend. The last market change indicates a sharp increase in price.

**3. RSI, PPO, and Expected Return**

*   **MRI:** 0.8 (Medium Investment Recommended)
*   **RSI:** 62.51
*   **PPO:** 0.408
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (5 shares - Safe - MRI:0.80) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2026-01-02)
*   **Recent (20 days) relative divergence change:** -6.1 (Short-term decline)
*   **Expected Return (%):** 13.1%

**Analysis:**

*   **MRI:** The Medium Investment recommendation suggests that the risk/reward profile is considered moderate.
*   **RSI:** An RSI of 62.51 indicates that the stock is approaching overbought territory (typically above 70) but is not there yet.
*   **PPO:** The PPO (Percentage Price Oscillator) is positive, confirming the recent uptrend.
*   **Hybrid Signal:** The hybrid signal recommends buying a significant portion of cash with a monthly investment, indicating a bullish but cautious approach. The recommendation to hold zero cash implies that the strategy favors being fully invested given the current outlook.
*   **Recent Divergence Change:** The negative change in relative divergence suggests a slight weakening in the stock's outperformance over the past 20 days. This is a signal of short-term decline.
*   **Expected Return:** A 13.1% expected return is attractive and suggests that the stock is expected to continue to outperform the S&P 500 in the long term.

**4. Recent News & Significant Events**

*   The news headlines are predominantly positive, highlighting reasons for recent price increases (chip-equipment rally, solid growth stock).
*   One headline mentions SteelPeak Wealth LLC trimming its holdings, but the overall sentiment seems bullish.
*   The news items generally support the recent positive price action and the outlook for the company.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (Mean: 1.79)
*   **Target Price:** Average: $169.83, High: $210.00, Low: $115.00

**Analysis:** The analyst consensus is a "Buy" with a mean rating of 1.79, suggesting strong positive sentiment. However, the current price of 185.06 is above the average target price of 169.83. This could mean that analysts haven't fully caught up to the recent price surge, or it could indicate that the stock is currently overvalued according to their models. The range in target prices is quite wide, reflecting some uncertainty in the outlook.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출    |
|------------|------|---------|
| 2025-10-24 | 1.24 | 5.32 B$ |
| 2025-04-25 | 1.04 | 4.72 B$ |
| 2025-01-31 | 0.93 | 4.38 B$ |
| 2024-10-28 | 0.86 | 4.17 B$ |
| 2025-10-24 | 0.86 | 4.17 B$ |

**Analysis:**

*   Both EPS (Earnings Per Share) and revenue have generally been increasing over the reported quarters.
*   The most recent quarter (2025-10-24) shows the highest EPS and revenue in the table, demonstrating strong financial performance.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-09-30   | $5.32B  | 50.43%        |
| 2025-06-30   | $5.17B  | 50.08%        |
| 2025-03-31   | $4.72B  | 49.02%        |
| 2024-12-31   | $4.38B  | 47.37%        |
| 2024-09-30   | $4.17B  | 48.05%        |

**Analysis:**  Revenue and profit margins have been consistently strong. The steady growth in both revenue and profit margins highlights the company's financial health and operational efficiency.

**Capital and Profitability:**

| Quarter      | Equity   | ROE      |
|--------------|----------|----------|
| 2025-09-30   | $10.19B  | 15.39%   |
| 2025-06-30   | $9.86B   | 17.44%   |
| 2025-03-31   | $9.51B   | 13.99%   |
| 2024-12-31   | $8.81B   | 13.52%   |
| 2024-09-30   | $8.47B   | 13.18%   |

**Analysis:** Equity has steadily increased, demonstrating the company's ability to generate and retain earnings.  The Return on Equity (ROE) is solid, indicating efficient use of shareholder equity to generate profits.

**7. Comprehensive Analysis (Summary)**

Lam Research (LRCX) is exhibiting strong financial performance and bullish market sentiment.  Key takeaways:

*   **Outperformance:**  LRCX has significantly outperformed the S&P 500, but the relative divergence suggests it may be near a peak.
*   **Growth:** The company demonstrates significant revenue and profit growth.
*   **Volatility:** LRCX is more volatile than the overall market (Beta > 1).
*   **Technical Indicators:**  Technical indicators (SMAs, RSI, PPO) generally support the current uptrend, though RSI suggests it's approaching overbought territory.
*   **News Sentiment:** Recent news headlines are predominantly positive.
*   **Analyst Consensus:**  Analysts generally rate the stock a "Buy," but the current price is above the average target price.
*   **Earnings:** Recent earnings show strong growth in both EPS and revenue.
*   **Financial Health:** The company has a healthy balance sheet with growing equity and strong ROE.
*   **MRI:** The MRI suggests a moderate level of risk.
*   **Hybrid Signal:** Recommends near-full investment.

**Overall Recommendation:**

Based on the data, LRCX appears to be a strong company with good growth prospects. However, the high valuation relative to analyst targets, approaching overbought conditions, and a recent negative divergence change indicate potential for a short-term correction. The investment strategy should take into account the medium-term growth potential as well as the immediate risks. The recent sharp price increase, while positive, also warrants caution.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.